The Natural Products, the Immune Diseases and the Cancers
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 1961
Special Issue Editor
Special Issue Information
Dear Colleagues,
The immune system consists of a matrix of cells, signal pathways and tissue reactivity. It maintains homeostasis in the living and aberrant function, either over- or down-regulated condition, can cause various disorders and jeopardize the hosts. Generally, it not only protects us from intruding pathogens, but is also essential in inherited or acquired immune diseases. In some special occasions, when an overactive immune system is against one’s own tissues, autoimmune diseases occur and they can exist in any organs of the body. Aside from these, a sustained inflammatory process is also deemed as one of the features in cancerous development. Although the pathophysiologies underlying different cancers are distinct, the immune system is often observed to be altered. Herein, immune microenvironments have emerged as one of the most prevalent topics in cancer research nowadays, either as predictive markers or therapeutic targets.
Immune-related diseases are sometimes serious and can cause everlasting destruction. However, current therapeutic choices are few and with limited efficacy from time to time. Our environment is provided with plentiful bioactive sources, allowing us to extract compounds for medication. These materials embrace the enhanced or suppressive abilities in modulating immunity, and there are chances that scientists may further synthesize them with semisynthetic or total synthetic techniques. In this way, it is crucial to understand and illustrate the detailed relationship between natural products and their immunomodulatory capacities. As mentioned above, the future of nature products is promising. They can serve as the alternate therapeutic choices and immune-related diseases, as well as cancers, can be benefited. In this regard, we would like to invite researchers worldwide to submit and share studies regarding, but not limit to, the following topics (Contributions from every corner of the natural products field are welcome, but must be based on concrete, chemically well-defined compounds, such as curcumin):
- Introducing immunomodulatory natural products from the environment, such as animals and plants.
- Discussing the mechanism of natural products in certain immunomodulatory pathways of immune-related diseases or cancers.
- Enlightening how natural products will be applied in immune-related diseases or cancers.
- Finding how immunomodulatory natural products inhibit the intruding pathogens or cancers.
- Discussing how to refine the production of natural products applied in immune-related diseases or cancers.
- Preclinical and clinical studies regarding the safety and/or effectiveness of natural products in diseases or cancers based on immune system.
- Review articles regarding the interaction between natural products and immune system or cancers.
Dr. Chi Chien Lin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- humans
- animals
- chemistry
- pharmacology
- anti-Inflammatory agents/pharmacology mechanisms
- anti-inflammatory agents/isolation and purification
- immune system diseases/drug therapy
- immune system diseases/immunology
- host–pathogen interactions/physiology
- meta-analysis as topic
- systematic reviews as topic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.